Page last updated: 2024-11-08
8-amino-8-demethylriboflavin
Description
8-amino-8-demethylriboflavin: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
8-amino-8-demethylriboflavin : A benzopteridine that is riboflavin in which the methyl group at position 8 has been replaced by an amino group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
ID Source | ID |
PubMed CID | 193403 |
CHEBI ID | 137336 |
SCHEMBL ID | 864292 |
MeSH ID | M0081109 |
Synonyms (9)
Synonym |
CHEBI:137336 |
8-amino-8-demethyl-d-riboflavin |
5178-05-2 |
1-(8-amino-7-methyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2h)-yl)-1-deoxy-d-ribitol |
8-amino-8-demethylriboflavin |
SCHEMBL864292 |
C21646 |
1-(8-amino-4-hydroxy-7-methyl-2-oxobenzo[g]pteridin-10(2h)-yl)-1-deoxypentitol |
DTXSID00966096 |
Drug Classes (4)
Class | Description |
benzopteridine | |
aromatic amine | An amino compound in which the amino group is linked directly to an aromatic system. |
tetrol | A polyol that contains 4 hydroxy groups. |
primary amino compound | A compound formally derived from ammonia by replacing one hydrogen atom by an organyl group. |
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (7)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 2 (28.57) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.34
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.34 (24.57) | Research Supply Index | 2.08 (2.92) | Research Growth Index | 4.42 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |